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1. Introduction 
Pharmacokintics deals with study of absorption, distribution, metabolism and excretion 
(ADME) of drugs. Pharmacokinetics, the study of time course of drug concentrations in the 
body, provides means of quantifying ADME parameters. In a clinical situation 
pharmacokinetics provides the practitioners a useful tool to design optimally beneficial drug 
dosage regimen for patient. Understanding pharmacokinetic principles allows clinician to 
make more rational therapeutic decisions. It also provides conceptual understanding to 
utilize withdrawal time to prevent drug residues that remain in the milk and edible tissues 
of food producing animals. 
Various steps involved in governing fate of drugs must be defined and quantified 
concentration of free, non-protein bound drug dissolved in serum or plasma is taken as 
reference point for pharmacokinetic analysis. Serum or plasma drug concentrations 
generally retract extra cellular fluid drug concentrations. A drug generally be present at its 
site of action in a tissue at sufficient concentration for a specific period to produce 
pharmacologic effect. This understanding is important in veterinary medicine where specific 
difference in any of ADME process significantly affect the extent and/or time course of drug 
absorption and disposition in the body. 
The concentration of antimicrobial achieved at site of infection depends on systemic 
availability of the drug, which varies with the dosage form and route of administration. The 
chemical nature and physicochemical properties of the drug influence the extent of 
absorption, pattern of distribution and rate of elimination. Effective antimicrobial therapy 
depends on triad of bacterial susceptibility, pharmacokinetic characteristics of the drug and 
the dosage regimen. 
Antimicrobials are administered either as flock medication in poultry and individually or 
group in swine and cattle. Systemic antimicrobial treatment is given orally through 
medicated feed or water, or by injections. Antimicrobials used in animals are generally the 
same to antimicrobials used in humans. Tetracyclines constitute the antimicrobials class 
quantitatively most used in animals followed by macrolides, lincosamides, penicillins, 
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sulfonamides, aminoglycosides, fluoroquinolones, cephalosporins and phenicols. The most 
common antimicrobial drug used as growth promoters include macrolides (tylosin and 
spiramycin), polypeptides (bacitracin), glycolipids (bambermycin), streptogramins 
(virginiamycin), glycopeptides (avoparcin), quinoxalines (carbadox and olaquindox) and 
ionophores (monensin and salinomycin). 
In human and veterinary practice the primarily concern in antimicrobial drug selection and 
use is the therapeutic outcome. Larger than therapeutic doses may lead to potential toxicity. 
Clinicians involved in the treatment of diseases in food animals have additional concern of 
the persistence of drug residue in the edible tissues after the disease has been treated. 
Adulteration of food supply with antimicrobial agents and other chemicals is growing 
concern to general public. 
2. Beta-lactam antibiotics: Penicillins, cephalosporins and related drugs 
Beta-lactam constitutes one of the most important and frequently used antimicrobial agents. 
The penicillins, cephalosporins, carbapenems, monobactams and -lactamase inhibitors are 
referred to as beta-lactams antibiotics. 
2.1 Penicillins 
The Penicillins are a large group of naturally occurring and semi-synthetic antibiotics. The 
penicillins are organic acids available as sodium or potassium salts. The Penicillins (Pka 2.7) 
are predominantly ionized in plasma. Penicillins in general have relatively small apparent 
volumes of distribution (0.2-0.3 L/kg) and short half-lives (0.5-1.2 hours) in all species of 
domestic animals. 
Penicillins are hydrolyzed & inactivated in the acidic pH of the stomach and therefore not 
absorbed orally except penicillin-V, aminopenicillins (ampicillin & amoxicillin) and 
isoxazolylpenicillins (cloxacillin, dicloxacilin & oxacillin). Aminopenicillins are absorbed 
poorly in horses and ruminants. Following oral administration, absorption of ampicillin in 
adult horses is only 2-3.5% (Sarasola & Mc Kellar, 1994; Ensink, et al, 1996). Systemic 
availability of oral amoxicillin is higher (2-10%) than ampicillin in adult horses. (Ensinic, 
et al, 1996; Wilson, et al, 1998). Serum concentrations of penicillins generally peak within 2 
hrs of PO administration. Penicillins in aqueous solution are rapidly absorbed from 
parenteral administration. Penicillins suspended in vegetable oil vehicles or sparingly 
soluble penicillins (procaine penicillin G and benzathine penicillin G) administered 
parenterely absorbs slowly resulting in longer persistence of plasma and tissue drug 
concentrations.  
Penicillins are widely distributed in body fluids & tissues. Protein binding of penicillins is 
low to moderate ranging from 30-60%. The penicillins have moderate volume of distribution 
and gets diffuse into extracellular fluid easily. Sufficient concentrations are achieved for 
susceptible bacteria in kidneys, synovial fluid, liver, lung, skin and soft tissues (Strover et 
al., 1981; Brown et al., 1982). Penicillins cross biologic membranes poorly. Entry of penicillin 
across blood-brain, placental, mammary or prostatic barriers is enhanced by inflammation 
or massive dose. 
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Penicillins are generally excreted unchanged except penicillin G, penicillin V, nafcillin, 
ticarcillin and aminopenicillins, which are metabolized to some extent by hydrolysis of ǃ–
lactam ring. The metabolites are inactive. Penicillins are eliminated entirely by Kidney 
(Glomerular   filtration and tubular secretion), which results in very high level in the urine 
except nafcillin, which is excreted mainly in bile. Active tubular secretion of penicillins can 
be comparatively inhibited by organic acids such as probenicid. Penicillins are also 
eliminated in milk in trace amounts and may persist for 90 hours. Penicillin residue in milk 
has been detected after intrauterine infusion also.  
2.2 Cephalosporins 
The pharmacokinetic characteristics of cephalosporins are typical of penicillins. Very few 
cephalosporins (cephalexin, cepharidine, cefadroxil & cefachlor) are acid stable and given 
orally. Pro-drug formations of such drugs enhance oral bioavailability. Cefadroxil is 
absorbed better in the foal than adult horses (Dufee et al., 1989). Most of the other 
cephalosporins are either administered IV or IM. Peak plasma concentration usually 
observes at ~ 30 min after parenteral administration.  
Cephalosporins are widely distributed through most body fluids & tissues including 
kidneys, lung, joints, bone & soft tissues except prostate & CNS. The volume of distribution 
is <0.3 L/kg. Protein biding for most cephalosporins is low in animals compare to human. 
For example ceftriaxone & cefazolin has high (85-95%) protein binding in human as 
compared to dogs (19-25%) (Popick et al., 1987). 
Cephalosporins are minimally metabolized in the liver. Several Cephalosporins like 
cephalothin, cephapirin, cephacetrile & cefotaxime are deacitylated to less active derivatives 
except ceftiofur, which is transformed to desfuroyl ceftiotur, which is largly responsible for 
its antibacterial efficacy. Most of the cephalosporins are excreted by renal tubular secretion 
except cefoperazone, which is largly excreted in the bile. In general cephalosporins have 
half-lives of 1 to 2 hours except some third generation cephalosporins like ceftiofur having 
half-life of 3-6 hr in cattle, 4 hours in dogs and 2.5 hr in horses. The pharmacokinetic 
parameters of some cephalosporins given to food animals like cattle, sheep and goat are 
given in Table 1. 
2.3 Other Beta-lactam antibiotics 
2.3.1 Carbepenems 
Carbepenems differ from penicillins by the substitution of a CH2 group for the sulphur in 
the five- membered ring attached to ǃ-lactam ring. They have very broad spectrum of 
activity and are resistant to most ǃ - lactamases. It includes imipenem, doripenem, 
ertapenem, meropenem and biopenem. The carbepenems are not absorbed orally, hence 
must be given parenterally. Following IV Injection, they are widely distributed to extra 
cellular fluid throughout body & achieve therapeutic concentrations in most tissues. 
Carbepenems  have low volume of distribution like penicillins & cephalosporins.Following 
IM administration imipenem has excellent bioavailability (>95%) and distributed widely 
throughout body except CSF. Imipenem gets largely eliminated through kidneys and gets 
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metabolized in renal tubules by a dihydropeptidase enzyme. Cilastatin, an inhibitor of renal 
dipeptidase decrease renal metabolism of impenem, leading to increase in elimination half-
life and decrease excretion of the drug largely in urine in active form. Half-life of 
carbepenem in patients having normal renal function is about 1 hour. 
 
 
 
Cephalosporin  
Animal 
species 
Route 
Dose 
(mg/kg)
Cmax  
(µg/ml)
Vd 
(L/kg)
T1/2  
(hr) 
AUC 
(0-∞)  
(g x  h/ml)
Cl  
(ml/min/kg
F (%) Reference 
Cephapirin 
Cows 
(lactating) 
      12.7  
Prades et 
al., 1988 
Cephalexin Calves    0.32 2.0  1.9  
Garg et 
al., 1992 
Cefazolin Calves    0.17 0.62  5.8  
Soback et 
al., 1987 
Ceftriaxone 
Goat 
IV 20 - 0.58 1.50 77.51 4.50 - Tiwari et 
al., 2009 IM 20 21.51 0.53 2.03 66.78 3.04 59 
Sheep 
IV 10 - 0.41 1.21 42.65 3.91 - Swati et 
al.,2010  IM 10 15.53 0.43 2.24 47.68 2.22 64 
   0.30   3.7  
Guerrini 
et al., 1985 
Calves 
(Buffalo) 
IV 10 - 0.48 1.27 40.0 4.40 - Gohil et 
al, 2009 IM 10 15.8 1.53 4.38 29.67 4.01 70.2 
Calves 
(Cow) 
IV 10 - 0.44 1.58 57.35 3.15 - Maradiya 
et al., 2010 IM 10 15.34 1.16 5.02 28.15 2.71 47 
Cefepime 
Goat 
IV 10 - 0.52 2.71 78.38 2.19 - Patni et 
al., 2008 IM 10 15.75 - 4.89 93.12 1.27 69 
Sheep 
IV 20 - 0.42 2.54 135.5 2.48 - Patel et 
al., 2010 IM 20 26.34 1.11 5.17 140.90 0.15 103 
Calves 
(Cow) 
IV 5 - 0.57 3.70 47.73 1.81 - 
Patel et 
al., 2006a 
IM 5 8.61 0.99 6.71 47.45 1.72 98 
Patel et 
al., 2006b 
Cefoxitin Calves     1.12    
Soback, 
1988 
Ceftazidime Sheep    0.36 1.60    
Rule at 
al., 1991 
Cefoperazone 
Calves     0.89    
Carli et 
al., 1986 
Sheep IV 47  0.16   2.7  
Guerrini 
et al., 1985 
Moxalactam      2.40    
Soback, 
1989 
Table 1. Pharmacokinetic parameters of selected cephalosporins administrated to food 
producing animals. 
2.3.2 Monobactams 
Monobactums are simple monocyclic ǃ-lactam compounds active only against bacteria or 
anaerobes. Aztreonam is a synthetic monobactam. It is not absorbed orally. It is 
administrators IV or IM having extensive distribution throughout body including CSF. It is 
having elimination half-life of 1.6 hour in man. 
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2.3.3 β-lactamase inhibitors 
Beta lactamase enzyme production is a major factor in constitutive or acquired resistance of 
bacteria to ǃ-lactam antibiotics. These drugs are combined with penicillins & cephalospirins 
to prevent degradation. It includes clavulanic acid, sulbactam and tazobactam. 
Clavulanic acid is a synthetic compound. It is combined with amoxillin (4:1) or ticarcillin 
(15:1). Clavulanic acid is well absorbed following oral administration having bioavailability 
more than 60%. It has widespread tissue distribution in extra cellular fluid but penetration 
in milk and CSF is poor. It gets largely eliminated unchanged in urine. Sulbactam 
(penicillinic acid sulfonate) is synthetic derivative of 6-aminopenicillinic acid. It is combined 
with either ampicillin or cefoperazone. The combination of sulbactam ampicillin gets 
absorbed after IM injections, distributes well into tissues and penetrates CSF through 
inflamed meninges. It is poorly absorbed orally but a pro-drug “sultamicillin” having 
double esters linkage of sulbactam with ampicillin gets absorbed from small intestine. 
Tazobactam is combined with piperacillin (piperacillin: tazobactam,  8:1) having 
pharmacokinetic properties similar to ǃ-lactam drugs.     
3. Tetracyclines 
Tetracyclines are a group of broad- spectrum antibiotics having a nucleus of four cyclic 
rings. The tetracyclines are crystalline amphoteric substances that can exist as acid or base 
salts. The tetracyclines are strong chelating agents. Its chelation with calcium causes tooth 
discoloration. Tetracyclines include chlortetracycline, oxytetracycline, tetracycline, 
doxycycline and minocycline. 
Tetracyclines have low absorption following oral administration except doxycycline. The 
tetracyclines are relatively lipophilic drugs that remains ionized in the gastrointestinal tract. 
Oral absorption of tetracyclines gets drastically reduced in the presence of food (Neilsen and 
Gurd-Hansen 1996). Its oral absorption decrease with co-administration of food, dairy 
products, polyvalent cations (Ca++, Mg++, Fe++, Al+++), Kaolin/pectin preparations, ion 
containing supplements and antacids. Tetracyclines (oxytetracycline) can be administrated 
IV or IM. All tetracycline produce varying degree of tissue irritation on parenteral 
administration. The bioavailability of   orally administrated oxytetracycline is 5% compared 
to 37% for chlortetracycline in non fasting calves. The long acting formulation of 
oxytetracycline used for IM administration to food animals have long acting effect due high 
dosage and prolonged persistence at the site of IM injection as a result of tissue irritation 
(Nouws et al.,1990). The bioavailability of most tetracyclines is very poor following oral 
administration in pigs. Intravenous administration of oxytetracycline is preferred over IM 
injection in horses as it results in higher and more persistent serum concentration.   
Tetracyclines bind to plasma proteins at varying degrees in different species of animals. 
Tetracyclines are widely distributed in most tissues including kidney, liver, lungs, bile and 
bones. Tetracyclines have volume of distribution in excess of 1.0 L/kg indicating higher 
drug concentration  intracellular or binding to tissues. Tetracyclines are more lipophilic than 
other classes of antibiotics hence it can cross lipid membrane easily. Minocycline and 
doxycycline attain high concentration in brain, ocular tissues, spinal fluid and prostate than 
other tetracyclines. Doxycycline has high affinity for intracellular accumulation than other 
tetracyclines (Davis et al., 2006). Tetracyclines cross the placenta and enter foetal circulation 
and are secreted in milk of lactating animals.  
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With exception of lipid soluble tetracyclines (doxycycline, minocycline), the tetracycline 
antibiotics are not metabolized to a significant extent in the body. About 60% of the dose 
gets eliminated in urine via glomerular filtration and 40% in faeces. Doxycycline gets 
excreted largely in the large intestine. Doxycycline & minocycline undergo entero-hepatic 
circulation, which contributes to their longer half-life (6-10 hr) than tetracycline that are 
eliminated mainly by renal excretion.       
4. Aminoglycosides 
The aminoglycosides are bactericidal natural and semi-synthetic antibacterials primarily 
used for treatment of gram negative infections and staphylococci. The group consists of 
hexose nucleus to which amino sugars are attached by glycosidic linkages. The 
aminoglycosides are basic polycations with pKa value ranging from 7.2 to 8.8. The chemical 
structure determines the antimicrobial activity, resistance patterns and inherent propensity 
to cause toxicosis. The group includes drugs like gentamicin, amikacin, kanamycin, 
apramycin, tobramycin, neomycin, streptomycin, dihydrostreptomycin, paromomycin and 
spectinomycin. 
The pharmacokinetics of the aminoglycosides is similar across most veterinary                          
species. However, variability within each animal population is large that necessitates close 
monitoring of serum concentrations to optimize efficacy and minimize toxicosis. Equines 
receiving multiple doses of parenteral amino-glycosides require therapeutic drug 
monitoring (Martin & Riviere, 1998)  
Aminoglycosides are poorly absorbed (<10%) from gastrointestinal tract because of their 
highly polar and cationic nature. Aminoglycosides given orally to young animals (neonate) 
with enteritis, significant absorption occur leading to violative tissue residues. The 
aminoglycosides are well absorbed following IM or SC injection. The peak serum 
concentration is achieved within 30 to 45 minutes following extravascular administration. 
Intravenous and intraperitoneal routes produce rapid effects but should be avoided because 
of serious side effects. Following intrauterine or intramammary infusion to cows, 
gentamicin is well absorbed and results in prolonged tissue residues. Absorption is 
extremely rapid and complete, if aminoglycosides are instilled into body cavities that 
contain serosal surfaces. 
Aminoglycosides are extensively distributed in extracellular fluid, as these are large 
molecules and highly ionized at physiological pH. They are poorly lipid soluble and have 
limited capacity to enter cells and penetrate cellular barriers. These drugs attain very low 
concentration in cerebrospinal, respiratory and ocular fluid. In the renal tubular cells and 
the endolymph and perilymph of inner ear, aminoglycoside attain high concentration 
causing nephro and oto-toxicity, respectively. Their apparent volume of distribution is 
relatively small (<0.35L/Kg). The amino glycosides binds poorly (<20%) to plasma proteins. 
Gentamicin is distributed into synovial fluid in normal horses; local inflammation may 
increase drug concentration in the joint. 
The aminoglycosides are not metabolized and are excreted largely as such (~90%) in urine 
by glomerular filtration. Plasma elimination half lives are short (1-2 hr) in domestic animals 
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having normal renal function. It increases to 24-48 hr in patients having renal insufficiency. 
The disposition of aminoglycosides varies among animals because of differences in 
glomerular filtration rates. The prolonged terminal elimination phase of aminoglycosides 
has major implications for veterinary therapeutics in food producing animals. 
Aminoglycosides accumulate in renal cortex for prolonged periods of time, resulting in 
tissue residues even after short periods of administration. 
5. Fluoroquinolones 
Fluoroquinolones are synthetic antibacterial agents introduced in veterinary medicine in the 
1980s. Currently available quinolones contain basic structure of 4-quinolone (Short for 4- 
oxo-1,4- hydroquinoline) with carboxylic acid moiety. Fluoroquinolones are amphoteric 
molecules having pKa ranging from 6.0-6.5 (Carboxy group) and 7.5-8 (nitrogen of 
piperazine group). Fluoroquinolones at physiological pH occurs as zwitterions. 
Fluoroquinolones  commonly used in veterinary medicine inciude enrofloxacin, difloxacin, 
orbifloxacin, marbofloxacin, ibafloxacin and danofloxacin. Other compounds having 
potential interest in veterinary practice include ciprofloxin, levofloxacin, moxifloxacin, 
gatifloxacin and pradofloxacin. 
The fluoroquinolones have good rate and extent of absorption after oral administration in 
monogastric animals and pre-ruminant calves. Presence of food has little effect on oral 
absorption. In dogs, cats and pigs, oral absorption of fluoroquinolones approaches to 100%, 
but in large animals it is less. Enrofloxacin is more lipid soluble than ciprofloxacin and has a 
higher oral bioavailability than ciprofloxacin in horses and small animals.  
The oral bioavailability of enrofloxacin is 63% (Giguere et al., 1996) in adult horses and 42% 
in foals (Bermingham et al., 2000). Absorption is complete following IM and SC Injection of 
fluoroquinolones. The pharmacokinetic parameters of some fluoroquinolones given to food 
animals like cattle, sheep, goat, pig and chicken are given in Table 2. 
Following absorption, fluoroquinolones show rapid and extensive tissue distribution due to 
hydrophilic nature and low (<50%) protein binding. In general, fluoroquinolones 
concentration in interstitial fluid, skin and bones are 35-100% of those obtained in serum, 
where as bronchial secretions and prostatic concentrations are two to three times of 
corresponding serum concentrations. Penetration into CSF is approximately 25% of serum 
concentration (Davis  et al., 2002). Fluoroquinones attain high intracellular concentrations in 
macrophages and neutrophils. Intracellular concentrations are 4 - 10 times greater than 
plasma concentrations.  
The fluoroquinolones are largely eliminated uncharged in the urine by glomerular filtration 
and active tabular secretion, except difloxacin, which is excreted largely (80%) in faeces. 
Parent compound as well as metabolites of some fluoroquinolones is excreted in bile and 
urine. Enrofloxacin undergoes de-ethylation to active metabolite ciprofloxacin. In cattle the 
proportion of ciprofloxacin in plasma was 25 - 41% following administration of enrofloxacin 
(Davis et al., 2002). The ciprofloxacin concentration residues were present in tissue of 
chicken 12 days after dosing of enrofloxacin (Anadon et al., 1995). Pefloxacin gets completed 
metabolized to active metabolite norfloxacin. The elimination half-life (3-6 hr) of 
fluoroquinolones is dependent on the drug and animal species.       
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Fluoro quinolone  
Animal 
species 
Route 
Dose 
(mg/kg)
Cmax  
(µg/ml)
Vd 
(L/kg) 
T1/2ǃ 
(hr) 
AUC 
(0-∞) 
(g x h/ml 
F (%) Reference 
Ciprofloxacin 
Sheep 
IV 5 - 1.67 1.88 8.40 - Patel et al., 
2004 IM 5 0.95 3.40 3.67 5.48 68 
Calves 
(cow) 
IV 5 - 1.67 1.80 7.90 - 
Bhavsar et al., 
2004 
Calves 
(Buffalo) 
IV 5 - 1.98 1.25 4.56 - 
Sarvaiya et al., 
2006 
Pigs IV 3.06 0.17 3.83 2.57 2.88 37 
Nouws et al., 
1988 
Chicken PO 5 4.67 2.0 9.0 78.04 70.0 
Atta and 
Sharif, 1997 
Levofloxacin 
Poultry 
(Broiler) 
IV 10 - 
3.25 
(Vdss) 
3.18 11.33 - Varia et al., 
2009 
PO 10 0.93 - 3.64 6.70 59.5 
Enrofloxacin 
Cattle 
SC 12.5 0.96 - 6.79 14.95 - 
Davis et al., 
2006 
IV 8 0.81 - 7.28 7.51 - 
Ter Hune et 
al., 2005  
IV 5  1.63 1.68 7.42  
Kaartinen et 
al., 1997 
IM 5 0.73  5.9  82 
SC 5 0.98  5.55  137 
 2.5  2.98 2.82 5.28  
Bergante et al., 
1999 
Goat IV 5 6.7 1.3 1.1 6.7  Rao et al., 2002 
Sheep 
- 5 2.69 1.15 4.8 57.5 98.07 
Bermingham 
and Papich, 
2002 
IM 2.5  2.18 3.73 5.47 85.0 
Mengozzi et 
al., 1996 
PO 2.5 0.78 1.3 3.8 10.4 60.6 
Pozzin et al., 
1997 
Pig IM 
2.5 0.61 3.5 7.73 9.94 95 
Richez et al., 
1997 
2.5 0.75 3.95 5.5 5.03 101 
Pijpers et al., 
1997 
Chicken 
IV 10.0 
1.88 
(PO) 
5.0 
(IV) 
5.6 16.17 89.2 
Knoll et al., 
1999 
PO 10.0 1.5 - 14 35 - 
Da Silva et al., 
2006 
Danofloxacin 
Cattle 
IV 6 1.7  4.21 9.72 - 
Ter Hune et 
al., 2005 
IM 1.25 0.28 2.04 2.25 132.85 289 
Shem-Tov et 
al., 1998 
IM 5 0.82  2.9 4.7 78 
Mann and 
Frame, 1992 
Goat SC 1.25 0.33 3.8 4.67 2.29 110 
Aliabdi and 
lees, 2001 
pig IM 5 0.8 - 8.0 6.0 76 
Mann and 
Frame, 1992 
Marbofloxacin Goat IM 2 1.9 
1.3  
(Vdss) 
7.2 8.44 100.7 
Waxman et al., 
2001 
Table 2. Pharmacokinetic parameters of selected fluoroquinolones administrated to food 
producing animals. 
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6. Sulphonamides and potentiated sulphonamides 
The sulphonamides are oldest antimicrobial compounds, derivatives of sulphanilamide 
which was obtained from the azo dye “prontosil”. Sulphonamides are white crystalline 
powders that are quite insoluble. They are more soluble at an alkaline pH than an acidic pH. 
Solubility of sulphonamides increases in the presence of another sulphonamide in the 
solution because it follow law of independent solubility. The sodium salts of sulphonamides 
are readily soluble in water. These solutions are highly alkaline (used for parenteral 
preparation) in reaction except sodium sulphonamide which is near neutral and used for 
ophthalmic instillation. The pKa values of sulphonamies range are from 10.4 (sulfanilamide) 
to 5.0 (sulfisoxazole). They exist in lipid soluble non-ionised form in biologic fluids of pH 
lower than their pKa. Sulphonamides commonly used in veterinary medicine include 
sulphadimethoxine, sulphamethazine (sulphadimidine),  sulphaquinoxaline,  
sulphamerazine,  sulphathiazole, sulphasalazine, sulphadiazine, Sulphabromomethazine, 
sulphaethoxypyridazine, sulphisoxazole and sulphachlorpyridazine. The potentiated 
sulphonamides are combination of a sulphonamide with diaminopyrimidine compounds 
(trimethoprim or ormethoprim). Potentiated sulphonamide combinations used in veterinary 
practice includes Trimethoprim - sulphadiazine, Trimethoprim - sulphamethaxazole, 
Trimethoprim - sulphachlorpyridazine and ormetoprim - sulphadimethoxine. 
Most sulphonamides (except gut acting and topical sulphonamides) get well absorbed 
following oral administration. The absorption rate is affected by the solubility of 
sulphonamides and presence of ingesta in the gastrointestinal tract. In general dogs, cats 
and birds absorb sulphonamides rapidly, pigs takes some time and ruminants require much 
longer time. In ruminants, age and diet markedly affect oral trimethoprim and 
sulphadiazine disposition in calves. Orally administered sulphadiazine (30mg/kg) was 
absorbed slowly in calves fed milk diets, with absorption slightly higher in ruminating 
calves. Trimethoprim was absorbed in pre-ruminant calves but not absorbed in mature 
ruminants after oral administration (Shoaf et al., 1987). 
Sulphonamides are widely distributed throughout body including soft tissues, CNS 
(cerebrospinal fluid) and joints (synovial fluid). Plasma protein binding varies from 15 -90 % 
depending on sulphonamide to sulphonamide and species to species. Extensive (>80%) 
protein binding increases half-life. Sulfonamides are weak acids and timethoprim is a weak 
base. Trimethoprim has higher volume of distribution than sulfonamide due to ion trapping 
of trimethoprim in tissues. Calculation of dosages of sulphonamides to maintain steady state 
of 100 µg/ml requires consideration of the extent of protein binding, apparent volume of 
distribution and half-life as it varies between individual within a species. 
Sulphonamides and trimethoprim are metabolized faster and more extensively by 
herbivores than carnivore or omnivores. Acetylation of NH2 group on N-4 is a major 
mechanism of metabolism. Hydroxylation of methyl group on the pyrimidine ring and 
carboxylation also occurs. Ruminants metabolize sulphonamides by acetylation pathways 
and acetylated metabolites are the major urinary metabolites in cattle, sheep and swine. 
Acetylated metabolites are less soluble than the parent compound and increase risks of renal 
tubular injury due to precipitation and crystal formation. The canines’ lacks the ability to 
acetyl ate sulphonamides, relying on alternate metabolic pathway. Glucuronide conjugation 
and aromatic hydroxylation are two additional pathway for sulphonamide metabolism. 
Sulphonamide metabolites are therapeutically inactive (N 4- acetyl metabolites) or have 
reduced therapeutic activity (hydroxy metabolites).  
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Sulfonamides are excreted in urine. Renal excretion mechanisms include glomerular 
filtration of free drug in the plasma, active carrier-mediated proximal tubular excretion of 
ionized unchanged drug and metabolites and passive reabsorption of nonionized drug from 
distal tubular fluid. Urinary alkalization increases both the fraction of dose that is 
eliminated by renal excretion and the solubility of sulphonamides in the urine. 
7. Peptide antibiotics: Polymyxins, glycopeptides and bacitracin 
7.1 Polymyxins 
Polymyxins are group of N-mono-acetylated decapeptides. Polymyxin B and polymyxin E 
(colistin) are chemically related and therapeutically useful. The polymyxins are not 
absorbed into the body when given orally. Polymyxin B sulfate or colistin methane 
sulphonate sodium is given parenterally for systemic therapy. Following absorption 
polymyxins bind moderately (70-90%) to plasma proteins. Polymyxins bind extensively to 
muscle tissues. It binds to mammalian cell membrane and accumulates following long term 
dosing. They are slowly excreted unchanged by glomerular filtration in the urine. The 
polymyxins are highly nephrotoxic damaging the renal tubular epithelial cells.  
7.2 Glycopeptides 
Vancomycin, teicoplanin and avoparcin are glycopeptide antibiotics. The former two have 
been considered as the drugs of “last resort” to treat serious infections due to drug resistant 
gram-positive bacteria in human. Vancomycin and avoparcin are used in veterinary 
medicine in some countries. 
Vancomycin is poorly absorbed following oral administration. Its tissue distribution is poor 
following parenteral administration. Most of the intravenously administered drug is 
excreted through the kidneys, with small proportion excreted in bile. Vancomycin 
hydrochloride is given IV as infusion and it requires monitoring in patients with renal 
impairment. Teicoplanin is not absorbed after oral administration. Absorption and 
distribution into tissue and extracellular fluid is excellent following IM Injection. It gets 
eliminated entirely in urine.  
7.3 Bacitracin   
It is polypeptide product derived from Bacillus subtilis. It is bactericidal to Gram-positive 
bacteria but has little activity on Gram-negative organisms. It is highly nephrotoxic after 
parenteral administration. It is only used for topical treatment of superficial infections of the 
skin and mucosal surfaces. In veterinary medicine it is used at low dose as growth promoter 
in chicken.  
8. Lincosamides, pleuromutilins and streptogramins 
8.1 Lincosamides 
Lincosamides are a group of monoglycoside antibiotics containing amino-acid like side 
chain. It includes lincomycin, clindamycin and pirlimycin. Lincosamides are basic 
compounds with pKa of  7.6. They have high lipid solubility and large apparent volume of 
distribution. 
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Lincomysin is rapidly but incompletely absorbed following oral administration (20-50%) in 
pigs (Hornish et al, 1987). Peak levels are achieved within 60 minutes following oral 
administration and 2-4 hr after IM Injection. It is well distributed in tissues (liver, kidney, 
muscle & skin) with low levels in CSF (Vd: 1-1.3 L/kg). Following oral administration most 
of the drug gets excreted through faeces (85%) and remainder in urine. Following IM 
Injection 38% gets excreted in faeces and 49% in urine. 
Clindamycin is 7- chlorolincomycin having better antibacterial effect compared to 
lincomycin. Clindamycin absorb better from gastrointestinal tract than lincomycin. It is 
distributed well to tissues and attains high intracellular concentration (Vd: 1.6-3.1 L/kg). It 
also achieves effective concentration in bone. Following parenteral administration half life 
ranges from 3.2 hr (IV) to 5-7 hr (IM or SC). It has excellent bioavailability (80-100%) 
following IM Injection.   
8.2 Pleuromutilins 
Tiamulin and valnemulin are semisynthetic derivatives of naturally occurring diterpene 
antibiotic pleuromutilin. Tiamulin hydrogen fumarate is used for oral administration 
whereas tiamulin base is used for Injection. Valnemulin hydrochloride is used as medicated 
feed premix. Tiamulin gets rapidly absorbed after oral administration in monogastric 
species but gets inactivated in rumen if given orally to ruminants. It has half life of 25 
minutes following parental administration (Ziv et al., 1983). It gets concentrated into milk as 
it is more lipophilic having pKa- 7.6. Valnemulin bioavailability exceeds 90% in pigs when 
given with feed. 
8.3 Streptogramins 
Streptogramins are a group of natural (virginiamycin, pristinamycin) or semisynthetic 
(quinupristin/dalfopristin) cyclic peptides. Virginiamycin is used in veterinary medicine as 
growth promoter (5-20 ppm). It is not absorbed after oral administration. Its use as growth 
promoter has been banned in several countries because of resistance in enterococcal isolates. 
9. Macrolides, azalides and ketolides 
The macrolide antibiotics are a group of structurally similar compounds containing 12-20 
atoms of carbon in lactone ring. Various combinations of deoxy sugars are attached to 
lactone ring by glycosidic linkages. Macrolides used in veterinary medicine include 
erythromycin, tylosin, spiramycin, tilmicosin and tulathromycin. Other macrolides like 
oleandomycin and carbomycin have been used as feed additives for growth promotion in 
food animals. 
9.1 Erythromycin 
It is base having pKa of 8.8. It is poorly soluble in water and unstable in gastric acid. 
Erythromycin base is absorbed well following oral administration but it is highly susceptible 
to degradation from gastric acids. Erythromycin base in entric-coated formulation or 
erythromycin estolate or stearate or phosphate or ethyl-succinate ester can be given orally. 
The stearate form is hydrolyzed in the intestine to the base and ethylsuccinate and estolate 
ester forms are hydrolyzed in the body to the active base. The presence of food in the 
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stomach interferes quite markedly with oral absorption. Aqueous solution of erythromycin 
glucophate and lactobionate forms can be given IV. Pain and irritation at site of Injection 
prohibits use of erythromycin by SC or IM routes. The drug is well distributed in the body, 
being concentrated in the tissue like lungs, liver, spleen, heart, kidney and bile, prostatic, 
seminal, pleural and peritoneal fluids. Prostatic fluid concentrations are approximately half 
that of serum concentration. Penetration of erythromycin to CSF is low. The drug is largely 
metabolized by demethylation and metabolites are excreted largely in bile, which is lost in 
faeces. Urinary excretion is only 3-5% of administrated dose. The drug has half life of 3-4 hr 
in cattle. 
9.2 Tylosin 
Tylosin is more extensively used as a feed additive to promote growth in food-producing 
animals. Tylosin is a weak base (pKa 7.1) and is highly lipid soluble. The drug has good 
absorption from gastro-intestinal tract. It is widely distributed in tissues like lung, liver, 
spleen, heart and kidney. It is metabolized in liver and excreted via the bile and feaces. The 
elimination half-life in dogs and cattle is about 1 hr with apparent volume of distribution of 
1.7 and 1.1 L/kg, respectively. The half-life is longer (4 h) in sheep, goat and pigs.  
9.3 Tilmicosin 
It is semisynthetic derivative of tylosin. It has slow absorption and low bioavailability (22%) 
in cows. It has large volume of distribution (>2 L/ kg), with accumulation and persistence in 
tissues like lung. The drug administrated to cow (10 mg/kg, SC) resulted in milk 
concentration > 0.8 μg/ml for eight to nine days (Ziv et al.,1995) 
9.4 Spiramycin 
Spiramycin has quite exceptional ability to concentrate in tissues, resulting in tissue 
concentrations reaching 25-60 times those of serum. Persistence of drug residues for 
prolonged periods limits its use in food producing animals. 
9.5 Tulathromycin 
Tulathromycin is an azalide derivative of erythromycin. It is rapidly and extensively 
absorbed from SC & IM injection in cattle and pigs having bioavailability of 90%. The drug 
has half-life of 90 hr. The apparent volume of distribution following IV administration is  
12 L/Kg. Lung concentrations are 25-80 times higher than serum concentrations. 
9.6 Roxithromycin, dirithromycin, clarithromycin and azithromycin 
The newer macrolides are acid stable, produce few gastro-intestinal side effects, have higher 
oral bioavailability and longer elimination half- lives and produce higher therapeutic tissue 
concentration as compared to erythromycin. Oral bioavailability of azithromycin is 97% in 
dogs and about 50% in cats and foals. Elimination half-life of azithromycin is 20 hr and 30 hr 
in foals and cats, respectively. Clarithromycin half-life (4.8 hr) is shorter than azithromycin 
but longer than erythromycin (1 hr) in foals. The major route of excretion is bile and 
intestinal tract for azithromycin. The major route of excretion for clarithromycin is kidney. 
Tissue concentration of azithromycin is 10-100 times of those achieved in serum. The 
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extensive tissue distribution of azithromycin is due to its concentration within macrophages 
and neutrophils. 
9.7 Ketolides 
Ketolides are members of a new semisynthetic 14 membered ring macrolide, with a 3-keto 
group instead of a ǂ-L cladinose on the erythronolide A ring. It includes telithromycin and 
cethromycin, which are given orally. Their pharmacokinetics display a long half-life as well 
as extensive tissue distribution and uptake into respiratory tissues and fluids, allowing once 
daily dosing 
10. Chloramphenicol and derivatives 
10.1 Chloramphenicol 
Chloramphenicol is a derivative of dichloroacetic acid and contains a nitrobenzene moiety. 
It is slightly soluble in water and freely soluble in propylene glycol and organic solvents. 
Chloramphenicol base or its palmitate salt is used for oral administration. Chloramphenicol 
palmitate is hydrolyzed in the small intestine by estrases, which release the free base form of 
chloramphenicol to systemic circulation. Chloramphenicol succinate is freely soluble in 
water and is used for IV or IM administration. It gets hydrolyzed in plasma to produce 
active drug. Pharmacokinetic parameters of chloramphenicol in food producing animal 
species are summarized in table 3. 
 
Animal 
species 
Route 
Dose 
(mg/kg) 
Formulation 
Vd 
(L/kg) 
T1/2 ß  
(hr) 
Reference 
Cattle 
IV 40 Base 0.35 2.81 
Sanders et al., 1988 IM 90 Base - 1.35 
SC 90 Base - 1.15 
Calves IV 25 
Base in 
Propylene 
Glycol 
1.03 (1 day old) 
0.81 (7 day old) 
0.90 (14  day old) 
0.69 (28 day old) 
1.38 (9 months 
old) 
7.56 (1 day old) 
5.96 (7 day old) 
4.0 (14  day old) 
3.69 (28 day old) 
2.47 (9 months old) 
Burrows et al., 1983 
Sheep 
IV 30 Base 0.69 1.70 
Dagorn et al., 1990 IM 30 Base - 2.71 
SC 30 Base - 17.93 
Goats 
IV 25 Succinate 1.68 1.22 
Kume and Garg, 
1986 
IV 25 Succinate 1.96 1.29 
IM 25 Succinate 3.02 1.46 
IM 25 Succinate 2.77 1.45 
IV 10 Succinate 0.31 1.47 
Abdullah and 
Baggot, 1986 
Pigs 
(Adult) 
IV 22 base 1.05 1.3 Davis et al., 1972 
Piglets IV 25 Base 0.94 12.7 
Martin and Weise, 
1988 
Chicken 
IV 20 Succinate 0.24 8.32 
Atef et al., 1991 IM 20 Succinate 0.44 7.84 
PO 20 Succinate 0.41 8.26 
Table 3. Pharmacokinetic parameter of chloramphenicol in food producing animal 
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Chloramphenicol is well absorbed from gastro-intestinal tract in monogastric and pre-
ruminant calves. The oral bioavailability in foals is 83%. Chloramphenicol palmitate is 
poorly absorbed in cats. Chloramphenicol administrated orally to ruminants gets 
inactivated in rumen. High lipid solubility and low plasma protein-binding (30-46%) enable 
it to attain effective concentration most tissues and body fluids including cerebrospinal fluid 
and central nervous system. It also get readily diffuse into milk and pleural and ascetic 
fluids. It also readily crosses the placenta and achieves high concentration in fetus. The drug 
has large volume of distribution (1-2.5 L/kg) due to its lipophilic nature. 
Chloramphenicol is metabolized in the liver. Phase-II glucuronidation is the principal 
pathway producing metabolite chloramphenicol glucuronide. Rapid metabolic clearance 
produces short half-lives in many species and requires frequent administration. The 
elimination half-life of chloramphenicol varies widely among species. It is short (1hr) in 
horses (Sisodia et al, 1975) and long (5-6 hr) in cats (Watson, 1991). Most of the absorbed 
chloramphenicol (80%) gets excreted into the urine as inactive metabolite via tubular 
secretion. 
10.2 Thiamphenicol 
Thiamphenicol is a semisynthetic structural analogue of chloramphenicol, in which the p-
nitro group has been replaced by a sulfomethoxyl group. Absorption and distribution are 
similar to those of chloramphenicol. Bioavailability in pre-ruminant lambs and calves is 60 
% following oral administration. It is well distributed in the body. Thiamphenicol is not 
eliminated by hepatic glucronide conjugation but excreted unchanged in the urine. The 
pharmacokinetics of thiamphenicol follow allometric scaling, in that values of elimination 
half-life and volume of distribution increase with body size (Castells , 2001). 
10.3 Florfenicol 
Florfenicol is a fluorinated derivative of thiamphenicol, in which the hydroxyl group has 
been replaced with fluorine. The oral bioavaibility of florfenicol is 89% in calves. 
Bioavailability following IM injection and intramammary infusion in lactating dairy cattle is 
38% and 54%, respectively. Florfenicol is well distributed into many tissues and fluids 
including lungs, muscle, bile, kidney and urine. Concentrations in brain and CSF are             
¼ to ½ , respectively of the corresponding concentrations in plasma. The drug has volume of 
distribution of 0.7-0.9 L/kg with low plasma protein binding (13-19%) in cattle. Most of the 
administrated dose gets excreted as the parent drug (64%) in urine of cattle. Florfenicol 
amine metabolites persist longer in tissues of cattle and are used as marker residue for 
withdrawal determination. The elimination half-life is 2-4 hr in cattle. The commercially 
available formulation of florfenicol is long-acting, so that “flip-flop” kinetics occur, where 
elimination is prolonged due to slow absorption from the injection site. 
11. Miscellaneous antimicrobials 
11.1 Ionophore antibiotics 
Carboxylic ionophore polyether antibiotics are streptomyces products used as growth 
promoters. Ionophore antibiotics used in veterinary medicine include monensin, lasalocid, 
maduramicin, narasin and salinomycin. 
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Following oral administration, monensin gets rapidly and completely absorbed in 
monogastric animals. In ruminants, oral bioavailability of monensin is 50%. Ionophore 
antibiotics do not attain higher concentration in tissues even at larger doses. Ionophores are 
rapidly and extensively metabolized in the liver and the metabolites are excreted in the bile 
and eliminated in the faeces. Horses are most sensitive to monensin toxicity because of very 
slow elimination as compared to cattle. 
11.2 Nitrofurans 
Nitrofurans are broad spectrum antimicrobials. They are used topically because of toxicity 
following systemic use. Nitrofurans are carcinogenic, hence their use in food animal has 
been banned in several countries (United States, Canada and European Union) of the world. 
In veterinary medicine, nitrofurazone is still used in non-food animals for skin infections. 
11.3 Nitroimidazoles 
The nitroimidazoles like metronidazole, dimetridazole, ronidazole, tinidazole and 
ipronidazole were once widely used in veterinary medicine but because of potential 
carcinogenicity, their use is banned in several countries (United States, Canada and 
European Union). Metronidazole is still used in companion animals against anaerobes & 
protozoa. 
Metronidazole is absorbed rapidly in monogastric animals following oral administration. 
The drug has oral bioavaibility of 75-85% in horses and 59-100% in dogs (Neff-Devis et al., 
1981; Steinman et al., 2000). It is lipophilic and widely distributed in tissues. It penetrates 
bone, abscesses and the central nervous system. It crosses the placenta and also distributed 
to milk attaining concentration similar to those in plasma. The drug has volume of 
distribution of 0.7 to 1.7 L/kg in mares, 0.95 L/kg in dogs and 0.8 L/kg in cow calves. 
Metronidazole is primarily metabolized in the liver by oxidation and conjugation. Parent 
drug & metabolites are excreted in urine & faeces. The drug has half-life of 3-4 hr in horses, 
8 hr in dogs and 1.9 hr in cow calves. Following oral administration in cow calves and 
sheep, half-lives were 4.38 & 1.72, respectively. Oral bioavailability in calves was 33.7 
percent (Patel et al., 1993; Bhavsar & Malik, 1994).  
11.4 Rifamycins 
Rifampicin is the most important synthetically modified derivative of natural antibiotics 
rifamycins. Rifampicin is soluble in organic solvents and water at an acidic pH. The drug 
gets rapidly absorbed after oral administration in calves, dogs and horses. In horses, 
bioavailability is low and administration with food prolongs the time to maximum serum 
concentration. Rifampin is very lipophilic and penetrates most tissues including milk, bone, 
abscesses and central nervous system. It is well distributed in milk. It crosses placenta and is 
teratogenic in rodents. The volume of distribution of rifampin in horses is 0.6 - 0.9 L/kg. It is 
highly bound to plasma proteins. The biotransformation and elimination of rifampin in 
animals is not well known. The elimination half-life of rifampin in horses is 6-8 hrs after IV 
injection and 12-13 hrs after oral administration. In dogs, elimination half-life is 8 hrs. 
Rifampin causes induction of hepatic enzymes in many species. 
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12. Animal origin foods and antimicrobial drug residues 
Food safety is one of the most significant issues for animal produce. During last several 
years great concern has been shown about the presence of chemical adulterants or residues 
especially antimicrobials and pesticides in the meat, poultry egg and milk. A chemical 
residue is either the parent compound or metabolite of that parent compound that may 
accumulate, deposit or otherwise be stored within the cells, tissues, organs or edible 
products of an animal following its use to prevent, control or treat animal disease or to 
enhance production. Residues can also result from unintentional administration of drugs or 
food additives. Contamination of the food supply with chemical residue is rarely an 
intentional act and usually results either from failure to observe the correct meat withdrawal 
or milk discard time for a drug after it has been used to treat a disease process in food 
animals or from accidental contamination of feed by chemicals or drugs.  
12.1 Regulation of drug residue 
Livestock and poultry production depends on drugs and other chemicals to protect animal 
health. Consumers are protected from adverse effects by regulation of chemicals and drugs 
and the detection of chemical and drug residues in foods of animals’ origin through national 
agencies (FDA in USA, Veterinary Drug Directorate in Canada, Medicines and healthcare 
products regulatory agency in UK and others). The codex alimentarius committee on 
residue of veterinary drugs in foods is subsidiary body of the world health organization 
(WHO) and the food and agriculture organization (FAO). One of the primary functions of 
the codex alimentarius is the establishment of the internationally acceptable concentrations 
of the veterinary drugs in food animal products. Extensive toxicological evaluations of the 
drugs and its metabolite are required before the drug is approved for use in food-producing 
animals. Based on the results of toxicity tests, regulatory agencies establish an acceptable 
daily intake (ADI). The ADI represents a level of daily intake of a chemical which, during an 
entire life time, appears to be without appreciable risk to the health of the consumer. The 
ADI is used to determine the maximum concentration of a marker residue in edible tissues, 
honey, milk or eggs that is legally permitted or recognized as acceptable. These acceptable 
concentrations are also termed as “tolerances” (USA) or “maximum residue limits” (MRL) 
(Canada and European union). 
12.2 Pharmacokinetics and drug residues 
Pharmacokinetics is the science of quantitating the change in drug concentration in the body 
over time as a function of the administered dose. How a drug or combination of drugs 
behaves in the body after administration not only is important from therapeutic point of 
view but is of paramount importance in order to prevent residues in the edible tissues after 
the disease process has been resolved and the animal is slaughtered. For determining 
withdrawal times of drug, half-life (t1/2) of drug is more relevant. The t1/2 of a drug by 
definition is the time taken for 50% of the drug in the animal to be eliminated from the body. 
It is calculated by the equation. 
 t1/2 = ln2/ slope or t1/2 = 0.693/ slope           (1) 
Half-life is influenced by biological factors like volume of distribution and elimination rate. 
The volume of distribution (Vd) is the quantitative estimate of the extent of the distribution 
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of the drug in the body and it influence t1/2 of the drug. It is proportionality constant 
relating the concentration of drug in the serum to the total amount of drug in the body. 
 Vd = amount of drug in the body / serum drug concentration    (2) 
In addition to Vd, the clearance (Cl) of the drug also play important role in determining the 
withdrawal time of the drug. Clearance quantitates the efficiency of the elimination process 
and is defined as the rate of drug elimination from the body relative to the concentration of 
drug in the serum. 
 Cl = rate of elimination / Serum drug concentration     (3) 
The t1/2 dependent on two functions: Volume of distribution and clearance. By combining 
term, an equation can be derived that reflects the influence of Vd and Cl on the t1/2 of a 
drug.  
 t1/2 = ln2 Vd/Cl or t1/2 = 0.693Vd/Cl          (4) 
For an orally or extrvascularaly administrated drug withdrawal can be derived as 
 Withdrawal time = 1.44 ln CCº (tolerance) (t1/2)     (5) 
Where Cº is the initial concentration of drug in the body derived by ratio bioavailability to 
Vd. 
The above equation is useful to gain a perspective on what the withdrawal time is relative to 
the terminal half-life. If the drug has a short half-life (eg. penicillin), the withdrawal time is 
short. However, If a drug (eg. An aminoglycoside) has a prolonged tissue half-life the 
withdrawal time could be very long. Similarly, a drug with a very low tissue tolerance has a 
longer withdrawal time. 
For lactating dairy cows and goats milk discard times are determined using pharmacokinetic 
principles. The milk discard or withdrawing time is the time after drug administration when 
the milk cannot be used for human consumption. This is determined by administering the 
drug and collecting and analyzing milk until drug concentrations are below the milk tolerance 
established for that drug. It is based on the half-life of the drug in the milk. Basic drugs like 
erythromycin have longer discard times than acidic drugs such as penicillin because the 
former tend to distribute more readily into milk due to pH partitioning phenomenon. 
Similarly, lipophilic drugs will tend to have longer milk discard times. 
13. Conclusion 
Food safety is one of the most significant issue faced by livestock owners and consumers of 
animal derived food. Residues of drugs and chemicals in food of animal origin raise special 
concern for human safety. Consumer concern about drug residue in animal food has led to 
reduction in demand in many countries. It has also disturbed international trade of food. 
Globally, food safety programs are advancing but formal training in drug residue 
prevention is limited. It is global need that Veterinarians should be acquainted with legal 
and regulatory issues concerning control of drug and other chemicals residues in food 
animals. The primary pharmacokinetic parameters used by veterinarians to prevent 
violative tissue residues are withdrawal time for meat and discard time for milk. 
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